About
Immunomodulatory therapeutic vaccines and immunotherapy treatments
Areas of Focus
Categories
Biologics & BiopharmaceuticalVaccineStem Cell & Cellular TherapySoutheastern U.S.
Clinical Trials (15)
View allTotal Trials
15
As Lead Sponsor
15
As Collaborator
0
Total Enrollment
317
By Phase
PHASE2: 6PHASE2/PHASE3: 2PHASE1/PHASE2: 7
By Status
COMPLETED: 7WITHDRAWN: 6SUSPENDED: 1TERMINATED: 1
Clinical Trials Pipeline15 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06557278Lead Sponsor
Combined AlloStim+Anti-PD-L1 in 4L MSS Metastatic Colorectal Cancer
PHASE2Withdrawn
Started: Nov 30, 2026 · Completed: Nov 30, 2028
NCT05033522Lead Sponsor
Immunotherapy for Advanced Liver Cancer
PHASE2/PHASE3Suspended
150 participants
Started: Aug 1, 2023 · Completed: Dec 1, 2026
NCT04441047Lead Sponsor
Universal Anti-Viral Vaccine for Healthy Elderly Adults
PHASE1/PHASE2Completed
40 participants
Started: Jul 12, 2021 · Completed: Nov 1, 2024
NCT04444622Lead Sponsor
Immunotherapy for Third Line Metastatic Colorectal Cancer
PHASE2Completed
29 participants
Started: Jul 12, 2021 · Completed: Mar 31, 2025
NCT01741038Lead Sponsor
AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer
PHASE2/PHASE3Withdrawn
Started: Dec 31, 2017 · Completed: Oct 31, 2020
Locations (1)
Headquarters
Tampa, FL, United States
Map
Loading map...